The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,330.00
Bid: 3,332.00
Ask: 3,340.00
Change: 16.00 (0.48%)
Spread: 8.00 (0.24%)
Open: 3,394.00
High: 3,394.00
Low: 3,298.00
Prev. Close: 3,314.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Apr 2018 15:47

RNS Number : 0774L
Spectris PLC
16 April 2018
 

Spectris plc: Director/PDMR Shareholding

 

 

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

On 16 April 2018, the Company's Executive Directors and PDMRs accepted grants made by Spectris plc ("the Company") of options over ordinary 5p shares pursuant to the terms of the Spectris plc Performance Share Plan ("the Plan"), as set out below.

 

Name

Position

Number of options granted under the Plan

John O'Higgins

Chief Executive

44,600

Clive Watson

Group Finance Director

28,280

Jo Hallas

Business Group Director

18,210

Andrew Harvey

Group Human Resources Director

13,450

Eoghan O'Lionaird

Business Group Director

18,210

Mark Serföző

General Counsel and Company Secretary

23,690

Robert (Robin) Stopford

Head of Corporate Development

13,100

Kenneth Smith

President, Asia Pacific

7,120

 

The total number of ordinary shares over which nominal-cost options were accepted on 16 April 2018 represents less than 0.1% of the Company's issued ordinary share capital on that date.

 

No consideration was paid for the grant of the awards.

 

The vesting of an award is subject to the continued employment of the participant and the satisfaction of performance conditions set by the Remuneration Committee of the Company. The awards will normally vest on the later of the third anniversary of grant and the determination of the performance conditions. To the extent that an award vests, it is exercisable for a period of seven years from the date of vesting. The awards made to John O'Higgins and Clive Watson are subject to an additional two-year holding period on vesting.

 

The option price payable by each participant on the exercise of his or her award is 5 pence per share.

 

The Company was informed of the above transactions on 16 April 2018.

 

1

Details of the persons discharging managerial responsibilities

a)

Name(s)

John O'Higgins, Chief Executive

Clive Watson, Group Finance Director

Joanna Hallas, Business Group Director

Andrew Harvey, Group Human Resources Director

Eoghan O'Lionaird, Business Group Director

Mark Serföző, General Counsel and Company Secretary

Robert Stopford, Head of Corporate Development

Kenneth Smith, President, Asia Pacific

2

Reason for the notification

a)

Position/status

See 1a above

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectris plc

b)

LEI

213800Z4CO2CZO3M3T10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date ; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 5p each

GB0003308607

b)

Nature of the transaction

Acceptance of a grant of options over ordinary shares of 5p each pursuant to the terms of the Spectris plc Performance Share Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

John O'Higgins - options over 44,600 ordinary shares

Clive Watson - options over 28,280 ordinary shares

Joanna (Jo) Hallas - options over 18,210 ordinary shares

Andrew Harvey - options over 13,450 ordinary shares

Eoghan O'Lionaird - options over 18,210 ordinary shares

Mark Serföző - options over 23,690 ordinary shares

Robert (Robin) Stopford - options over 13,100 ordinary shares

Kenneth Smith - options over 7,120 ordinary shares

 

 

d)

Aggregated information

Aggregated Volume

n/a

Price

n/a

e)

Date of the transaction

16 April 2018

f)

Place of the transaction

Outside a trading venue

     

 

Name of contact and telephone number for queries:

 

Rebecca Dunn

Deputy Company Secretary

01784 470 470

 

For and on behalf of Spectris plc

LEI: 213800Z4CO2CZO3M3T10

 

Date: 16 April 2018

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUCCCUPRGCQ
Date   Source Headline
9th May 20245:23 pmRNSDirector/PDMR Shareholding
2nd May 20247:00 amRNSQ1 2024 trading update
1st May 20249:50 amRNSTotal Voting Rights
23rd Apr 20245:57 pmRNSDirector/PDMR Shareholding
9th Apr 20243:14 pmRNSDirector/PDMR Shareholding
8th Apr 20245:30 pmRNSHolding(s) in Company
3rd Apr 20246:26 pmRNSTransaction in Own Shares
3rd Apr 20245:20 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSDivestment of Red Lion Controls completed
2nd Apr 20246:26 pmRNSTransaction in Own Shares
2nd Apr 202410:30 amRNSTotal Voting Rights
28th Mar 20246:29 pmRNSTransaction in Own Shares
28th Mar 202410:00 amRNSDirectorate Change
27th Mar 20245:56 pmRNSTransaction in Own Shares
27th Mar 20249:45 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20246:23 pmRNSTransaction in Own Shares
20th Mar 20246:44 pmRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:59 pmRNSTransaction in Own Shares
18th Mar 202411:37 amRNSDirector and Board Committee Membership Change
15th Mar 20246:10 pmRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20246:28 pmRNSTransaction in Own Shares
12th Mar 20246:06 pmRNSTransaction in Own Shares
11th Mar 20246:02 pmRNSTransaction in Own Shares
11th Mar 202412:33 pmRNSDirector/PDMR Shareholding
8th Mar 20246:00 pmRNSTransaction in Own Shares
8th Mar 20242:59 pmRNSDirector/PDMR Shareholding
7th Mar 20245:27 pmRNSTransaction in Own Shares
7th Mar 202411:32 amRNSDirector Declaration
6th Mar 20246:07 pmRNSTransaction in Own Shares
5th Mar 20246:03 pmRNSTransaction in Own Shares
4th Mar 20245:48 pmRNSTransaction in Own Shares
1st Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 202410:00 amRNSTotal Voting Rights
1st Mar 20247:46 amRNSDirector Declaration
29th Feb 20246:02 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSFinal Results
28th Feb 20246:05 pmRNSTransaction in Own Shares
27th Feb 20246:04 pmRNSTransaction in Own Shares
26th Feb 20245:59 pmRNSTransaction in Own Shares
23rd Feb 20246:03 pmRNSTransaction in Own Shares
22nd Feb 20245:34 pmRNSTransaction in Own Shares
21st Feb 20245:58 pmRNSTransaction in Own Shares
20th Feb 20245:41 pmRNSTransaction in Own Shares
19th Feb 20245:38 pmRNSTransaction in Own Shares
16th Feb 20245:58 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.